These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26003609)

  • 1. Dialysate fluid endotoxin: assaying claims to cleanliness.
    Meyer KB
    Am J Kidney Dis; 2015 Jun; 65(6):817-9. PubMed ID: 26003609
    [No Abstract]   [Full Text] [Related]  

  • 2. Dialysis fluid endotoxin level and mortality in maintenance hemodialysis: a nationwide cohort study.
    Hasegawa T; Nakai S; Masakane I; Watanabe Y; Iseki K; Tsubakihara Y; Akizawa T
    Am J Kidney Dis; 2015 Jun; 65(6):899-904. PubMed ID: 25641063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efforts to reduce the endotoxin levels in dialysate.
    Takamiya T
    Contrib Nephrol; 1994; 108():46-52. PubMed ID: 8039397
    [No Abstract]   [Full Text] [Related]  

  • 4. Ultrapure dialysate improves iron utilization and erythropoietin response in chronic hemodialysis patients - a prospective cross-over study.
    Hsu PY; Lin CL; Yu CC; Chien CC; Hsiau TG; Sun TH; Huang LM; Yang CW
    J Nephrol; 2004; 17(5):693-700. PubMed ID: 15593037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyrogenic reactions in patients receiving conventional, high-efficiency, or high-flux hemodialysis treatments with bicarbonate dialysate containing high concentrations of bacteria and endotoxin.
    Gordon SM; Oettinger CW; Bland LA; Oliver JC; Arduino MJ; Aguero SM; McAllister SK; Favero MS; Jarvis WR
    J Am Soc Nephrol; 1992 Mar; 2(9):1436-44. PubMed ID: 1627766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contamination of dialysis water and dialysate. A survey of 30 centers.
    Bambauer R; Schauer M; Jung WK; Daum V; Vienken J
    ASAIO J; 1994; 40(4):1012-6. PubMed ID: 7858320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The level of endotoxins in hemodialysis water and dialysate].
    Skarupskiene I; Bumblyte IA; Kuzminskis V
    Medicina (Kaunas); 2007; 43 Suppl 1():81-4. PubMed ID: 17551282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dialysis purity on uremic dyslipidemia.
    Schiffl H; Lang SM
    Ther Apher Dial; 2010 Feb; 14(1):5-11. PubMed ID: 20438514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteria and endotoxin removal from bicarbonate dialysis fluids for use in conventional, high-efficiency, and high-flux hemodialysis.
    Oliver JC; Bland LA; Oettinger CW; Arduino MJ; Garrard M; Pegues DA; McAllister S; Moone T; Aguero S; Favero MS
    Artif Organs; 1992 Apr; 16(2):141-5. PubMed ID: 10078235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a phosphorus-enriched dialysate in a hypercatabolic renal failure patient receiving intensive hemodialysis therapy.
    Zabaneh RI; Bhatt DM; Yu AW; Tiwari P; Lai CI; Leehey DJ; Ing TS
    Nephron; 1996; 72(4):696-8. PubMed ID: 8730447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrapure dialysate reduces plasma levels of beta2-microglobulin and pentosidine in hemodialysis patients.
    Furuya R; Kumagai H; Takahashi M; Sano K; Hishida A
    Blood Purif; 2005; 23(4):311-6. PubMed ID: 15980621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should ultra-pure dialysate be mandatory?
    Lonnemann G
    Nephrol Dial Transplant; 2000; 15 Suppl 1():55-9. PubMed ID: 10737168
    [No Abstract]   [Full Text] [Related]  

  • 13. The level of endotoxins in hemodialysis water and dialysate in Lithuanian hemodialysis centers.
    Skarupskienė I; Bumblytė IA; Tamošaitis D; Venterienė J; Kuzminskis V
    Medicina (Kaunas); 2010; 46(8):556-60. PubMed ID: 20966633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of inflow of endotoxin and its fragments in patients on maintenance hemodialysis.
    Suzuki H; Honda H; Kato N; Michihata T; Takahashi K; Shishido K; Akizawa T
    Blood Purif; 2011; 31(4):268-75. PubMed ID: 21242680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of bacteria in dialysate and its antibody in long-term hemodialysis patients.
    Yamagami S; Adachi T; Sugimura T; Kishimoto T; Maekawa M; Niwa M; Shaldon S
    ASAIO Trans; 1989; 35(3):331-3. PubMed ID: 2597475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How should dialysis fluid be individualized for the chronic hemodialysis patient? Potassium.
    Rachoin JS; Weisberg LS
    Semin Dial; 2008; 21(3):223-5. PubMed ID: 18363596
    [No Abstract]   [Full Text] [Related]  

  • 17. Dialysis water and fluid purity: more than endotoxin.
    Glorieux G; Neirynck N; Veys N; Vanholder R
    Nephrol Dial Transplant; 2012 Nov; 27(11):4010-21. PubMed ID: 22844107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How should dialysis fluid be individualized for the chronic hemodialysis patient? Bicarbonate.
    Uribarri J
    Semin Dial; 2008; 21(3):221-3. PubMed ID: 18363599
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of a contamination free 6 valve injector inline monitoring system for endotoxin measurement in dialysate.
    Miyasaka T; Matsuda Y; Sakai K; Mochizuki S; Tanakai S
    ASAIO J; 2002; 48(4):389-93. PubMed ID: 12141469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How should dialysis fluid be individualized for the chronic hemodialysis patient? Sodium.
    Flanigan MJ
    Semin Dial; 2008; 21(3):226-9. PubMed ID: 18363598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.